Biogen Inc. (BIIB) is listed on NASDAQ in Biotech Stocks. It is $218.46, -1.37%, with a $32.3B market cap. RSI is 60.5, near overbought. The latest reported quarter beat estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 60.5 Near Overbought
Market Cap $32.3B
Volume 320.6K
Fundamentals — 10-Q Q1 2026
Revenue $2.5B
Net Income $319.5M
EPS $2.15
Gross Margin 73.3%
Net Margin 12.9%
Debt / Equity 0.3x
P/E Ratio 101.6x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Minor Lloyd | Director | Sell | 1,186 | $202.15 | $239,750 | 2026 Aug 4 |
| Singhal Priya | Head of Development | Sell | 517 | $133.55 | $69,045 | 2025 Sep 2 |
| Izzar Rachid | Head of Global Product Strat. | Sell | 2,223 | $135.00 | $300,105 | 2025 Jul 8 |
| Singhal Priya | Head of Development | Sell | 3,806 | $126.25 | $480,508 | 2025 May 19 |
| Dorsa Caroline | Director | Buy | 1,235 | $122.72 | $151,559 | 2025 May 2 |
| Sherwin Stephen A | Director | Sell | 8,760 | $150.02 | $1.3M | 2025 Mar 7 |
| Singhal Priya | Head of Development | Sell | 110 | $157.21 | $17,293 | 2024 Dec 9 |
| Singhal Priya | Head of Development | Sell | 431 | $204.22 | $88,019 | 2024 Sep 3 |
| Singhal Priya | Head of Development | Sell | 93 | $213.09 | $19,817 | 2024 Apr 2 |
| Singhal Priya | Head of Development | Sell | 262 | $221.23 | $57,962 | 2024 Feb 22 |
| Singhal Priya | Head of Development | Sell | 108 | $221.49 | $23,921 | 2024 Feb 16 |
| Rowinsky Eric K | Director | Buy | 455 | $222.54 | $101,256 | 2024 Feb 15 |
| Singhal Priya | Head of Development | Sell | 419 | $239.45 | $100,330 | 2024 Feb 12 |
| Singhal Priya | Head of Development | Sell | 634 | $245.93 | $155,920 | 2024 Feb 2 |
| Singhal Priya | Head of Development | Sell | 110 | $248.00 | $27,280 | 2023 Dec 11 |
| Singhal Priya | Head of Development | Sell | 431 | $269.43 | $116,124 | 2023 Sep 5 |
| Singhal Priya | Head of Development | Sell | 81 | $282.87 | $22,912 | 2023 Jul 3 |
| Gregory Ginger | EVP, Human Resources | Sell | 2,681 | $300.00 | $804,300 | 2023 Apr 28 |
| Singhal Priya | Head of Development | Sell | 91 | $277.11 | $25,217 | 2023 Apr 4 |
| Singhal Priya | Head of Development | Sell | 568 | $270.06 | $153,394 | 2023 Mar 28 |
Other Biotech Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $137.93 | 63.6 | $55.1B |
| | $432.33 | 66.2 | $233.7B |
| | $145.64 | 60.3 | $180.6B |
| | $176.24 | 62.2 | $9.9B |
| | $153.99 | 40.2 | $15.7B |
| | $8.05 | 54.2 | $8.5B |
| | $72.36 | 58.5 | $11.3B |
| | $54.45 | 50.2 | $13.5B |
Take BIIB further
- Browse Biotech Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put BIIB in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Biogen Inc. next reports.
Set alerts on BIIB
Get notified when Biogen Inc. hits your price targets or technical conditions are met.
Get Started Free